3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Neoplasms
24
Breast Neoplasms
11
Prostatic Neoplasms
10
Colorectal Neoplasms
10
Hematologic Neoplasms
7
Ovarian Neoplasms
6
Lung Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Advanced Cancer
4
Uterine Cervical Neoplasms
3
Rectal Neoplasms
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Sarcoma
2
Peritoneal Neoplasms
2
Pain
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Melanoma
2
Low Anterior Resection Syndrome
2
Hematopoietic and Lymphoid System Neoplasm
2
Fatigue
2
Endometrial Neoplasms
2
Depression
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Neoplasms
2
Brain Neoplasms
2
Bone Neoplasms
2
Interventions
Iodine-131
11
Thyrotropin Alfa
9
Sorafenib
8
lenvatinib
6
Thyroidectomy
6
vandetanib
5
Sunitinib
5
Saline Solution
5
pazopanib
4
Triiodothyronine
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Vemurafenib
3
Thyroxine
3
Radiotherapy
3
Everolimus
3
Dexmedetomidine
3
Control Groups
3
Cisplatin
3
AZD 6244
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
trametinib
2
tipifarnib
2
romidepsin
2
dabrafenib
2
belinostat
2
Trastuzumab
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thyroid Neoplasms
×
Interviews as Topic
×
Clear all
NCT06322160
2024-09-19
HANSOM
Royal Marsden NHS Foundation Trust
Completed
19 enrolled